Associations Between the Maternal Diet Index and Childhood Asthma: The NorthPop and Healthy Start Cohorts

Stina Bodén1,2, Carina Venter2,3, Kaci Pickett-Nairne4

  • 1Department of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden.

PubMed

Insights

The Maternal Diet Index (MDI) did not predict childhood asthma in a Swedish cohort, unlike in a US study. This suggests the MDI may not be universally applicable for assessing pregnancy diet and offspring asthma risk.

Area of Science:

  • Reproductive Health
  • Pediatrics
  • Nutritional Science

Background:

  • A novel Maternal Diet Index (MDI) was developed and validated in the US Healthy Start cohort to assess maternal dietary intake during pregnancy.
  • The MDI characterizes intake associated with offspring asthma and allergies.

Purpose of the Study:

  • To externally validate the asthma-related findings of the MDI in the Swedish NorthPop Birth Cohort Study.
  • To characterize the dietary patterns and demographics of both the NorthPop and Healthy Start cohorts.

Main Methods:

  • The MDI was calculated using seven dietary components, with specific foods weighted for their association with offspring asthma/allergies.
  • Childhood asthma incidence was determined via doctor diagnoses.
  • Time-to-event analysis (Weibull) was used to evaluate the association between the MDI and offspring asthma.

Main Results:

  • The NorthPop cohort exhibited significantly different mean MDI values compared to Healthy Start (p < 0.001).
  • In NorthPop, a Maternal Diet Index (MDI) above the median was not a significant independent predictor of childhood asthma after full adjustment (HR 0.84; p = 0.428).
  • The original Healthy Start cohort showed a significant association between a higher MDI and reduced asthma risk (HR 0.41; p < 0.0001).

Conclusions:

  • The Maternal Diet Index (MDI) did not demonstrate utility as an independent predictor of offspring asthma in the NorthPop cohort, which has different demographics and dietary patterns.
  • Further validation in diverse populations is required to establish the generalizability of the MDI.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.2K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K